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CASE STUDY
Tsukamurella tyrosinosolvens bacteremia 
with coinfection of Mycobacterium bovis 
pneumonia: case report and literature review
Chang‑Hung Chen1*, Chao‑Tai Lee2 and Tsung‑Chain Chang3
Abstract 
Introduction: We describe an immunocompromised patient with Tsukamurella tyrosinosolvens bacteremia and coin‑
fection of Mycobacterium bovis pneumonia.
Case Description: A 75‑year‑old male was admitted to our hospital complaining of persistent fever with general 
malaise. His medical history showed that he had diabetes mellitus (HbA1C 9.2%). A chest computed tomography (CT) 
showed left upper lung consolidation . Two sets of blood culture at admission finally showed Tsukamurella tyrosinosol-
vens. Moreover, three transbronchoscopy washing specimen cultures revealed Mycobacterium bovis.
Discussion and Evaluation: The organism Tsukamurella tyrosinosolvens was identified using conventional bio‑
chemical identification methods, PCR‑restriction DNA fragment analysis, and 16S rRNA gene sequencing. The clinical 
mycobacterial isolates were identified to the species level by combining Polymerase Chain Reaction (PCR) with an 
oligonucleotide microarray to detect the M. bovis amplicons.
Conclusion: According to our literature review, our patient’s case was the first of a coinfection with Tsukamurella 
tyrosinosolvens and Mycobacterium bovis. Prolonged antibiotic treatment and underlying disease control are necessary 
for this type of patient.
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Case report
A 75-year-old male was admitted to our hospital com-
plaining of persistent fever with general malaise for 
approximately 1  week. The patient had a productive 
cough and his medical history showed that he had dia-
betes mellitus (HbA1C 9.2%), hypertensive cardiovascu-
lar disease, and chronic obstructive pulmonary disease. 
He used oral medication and an inhaled bronchodilator 
to control his aforementioned diseases. In the admission 
survey, a complete blood count revealed that the patient 
had leukocytosis (WBC 21,000  μL). Moreover, a bio-
chemistry survey showed that he had an elevated C-reac-
tive protein level (20.3 mg/dl). A chest X-ray revealed that 
his left upper lobe was consolidated. The blood culture 
and sputum culture were performed at the admission 
under the impression of pneumonia. First, intravenous 
third-generation cephalosporin (ceftriaxone) combined 
with macrolide (azithromycin) were used. The patient’s 
clinical symptoms improved slowly, but he developed 
a high fever. A chest computed tomography (CT) per-
formed 1  week later still showed left upper lung con-
solidation (Fig. 1). The bacteria laboratory then reported 
gram-positive bacilli growth in the patient’s blood cul-
ture, and the acid-fast stain of the bacteria in blood speci-
men was also revealed to be positive. Nocardia spp. was 
highly suspected. We performed a bronchoscopy for 
the lung lesion, and multiple white cheese-like plaque 
coatings were observed over the left upper lobe bron-
chial orifice. The transbronchoscopy washing, brush-
ing, and biopsy were performed. The sputum specimen 
direct smear showed acid-fast stain positive bacilli, and 
a biopsy specimen showed granulomatous inflammation. 
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According to the blood culture data and bronchoscopy 
results, a Nocardia spp. pulmonary infection with sepsis 
was highly suspected. Hence, we changed the antibiotics 
to intravenous carbapenum (imipenem) and sulfonamide 
trimethoprim. The patient’s clinical condition improved 
gradually. After 2  weeks, two sets of blood culture at 
admission finally showed Tsukamurella tyrosinosolvens. 
Moreover, three transbronchoscopy washing specimen 
cultures revealed Mycobacterium bovis 1 week later. We 
started isoniazid, rifabutin, and ethambutol treatment for 
the lung lesion immediately. The use of imipenem was 
3 weeks and the sulfonamide and trimethoprim treatment 
was maintained for 1 month. Furthermore, the antituber-
culosis treatment was maintained for 12  months. After 
medical management, the patient’s chest X-ray survey 
and physical condition markedly improved.
Microbiology and methods
Gram-positive, weakly acid-fast bacilli were isolated from 
blood cultures (Bactec FX system, Becton–Dickinson 
and Company, Sparks, MD). The isolate grew effectively 
at 37 °C on a blood agar plate. The colonies were 2–5 mm 
in diameter, dry, rough, branched, and had a slightly yel-
lowish pigment appearance. The biochemical profile of 
the isolate was catalase-positive and urease-positive, and 
it hydrolyzed tyrosine but could not hydrolyze xanthine 
or casein in a Nocardia agar plate (Creative Media Prod-
ucts Ltd, New Taipei City, Taiwan).
Genotypic identification was performed using 16S 
rRNA gene sequencing. The 16S rRNA gene was ampli-
fied by primers 11F (5′-GTTTG ATCCTGGCTCAG-3′) 
and 1512R (5′-GGYTACCTTGTTACG ACTT-3′). 
Amplification was executed in an Applied Biosystems 
2720 thermal cycler (Applied Biosystems, Taipei, Tai-
wan). The PCR reaction mixture (25 μL) contained 2.5 μL 
of genomic DNA, 1× KAPA 2G Fast HotStart ReadyMix, 
and 1  μM forward and reverse primers. After an initial 
denaturation at 95  °C for 3  min, 10 cycles of amplifica-
tion (95  °C for 15 s and 60  °C for 50 s) and 36 cycles of 
amplification (95  °C for 15  s, 55  °C for 30  s, and 72  °C 
for 20  s) were conducted. The amplicon was purified 
and sequenced. The sequences obtained (1046  bp) were 
matched to that of Tsukamurella tyrosinosolvens present 
in the GenBank database by using the BLAST algorithm 
(http://www.ncbi.nlm.nih.gov/blast).
The transbronchoscopic washing specimens were 
decontaminated using N-acetyl-l-cysteine (NaLC) (0.5% 
final concentration)–NaOH (2% final concentration), and 
concentration by centrifugation was performed. Part of 
the sediment was used for the acid fast smear, which was 
then stained using auramine-rhodamine fluorochrome 
staining. Part of the NaLC–NaOH sediment or ster-
ile specimen was inoculated onto a Löwenstein–Jensen 
solid medium and into a 7H12 broth liquid medium 
that was monitored for growth by using the Bactec 960 
instrument.
The BACTEC™ MGIT™ 960 (Becton–Dickinson and 
Company) is a liquid broth media useful for recovering 
mycobacteria from clinical samples. In this study, sam-
ples were digested and decontaminated using the stand-
ard sodium hydroxide NaLC–NaOH method. Once a 
positive signal was provided by the BACTEC system, a 
Ziehl–Neelsen staining was performed, and the pres-
ence or absence of serpentine cording morphology was 
observed. The clinical mycobacterial isolates were identi-
fied to the species level by combining Polymerase Chain 
Reaction (PCR) with an oligonucleotide microarray to 
detect the M. bovis and M. tuberculosis amplicons.
Discussion
Tsukamurella species are categorized to the order Actin-
omycetales. They are obligate aerobic, gram-positive, par-
tially acid-fast, nonmotile bacilli (Schwartz et  al. 2002). 
Tsukamurella bacteria have many features very similar 
with other Actinomycetales, such as Nocardia, Rhodococ-
cus, Gordonia, and rapidly growing Mycobacterium bac-
teria. Using the standard biochemical tests, Tsukamurella 
species might be misidentified as belonging to one of 
these genera (Alcaide et  al. 2004). Infections of Tsuka-
murella species mostly relate to an immunocompromised 
condition (malignancy, postchemotherapy, AIDS, and 
chronic renal failure) and the use of intravascular cathe-
ters and prosthetic devices (Schwartz et al. 2002; Alcaide 
et al. 2004; Granel et al. 1996; Larkin et al. 1999). Clini-
cal syndromes in reported cases of Tsukamurella infec-
tion include bacteremia (Schwartz et al. 2002), cutaneous 
infection (Schwartz et  al. 2002), lung infection (Alcaide 
et al. 2004), conjunctivitis (Elshibly et al. 2005), infection 
Fig. 1 The chest CT shows left upper lung consolidation
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of a knee prosthesis and defibrillator (Granel et al. 1996; 
Larkin et al. 1999), and brain abscess (Sheng et al. 2009).
Accurately identifying Tsukamurella spp. by using 
phenotypic methods is difficult. The underreporting of 
Tsukamurella spp. resulted from the similarity of this 
genus to other more common pathogens expected in 
immunocompromised patients, such as Mycobacterium 
(Stanley et  al. 2006). The culture-medium morphol-
ogy, slow growth, and weak acid-alcohol-fastness char-
acteristics of Tsukamurella, will cause misdiagnoses of 
Corynebacterium, Rhodococcus, Nocardia, Gordonia, 
or Mycobacterium species infections. A PCR-restriction 
fragment-length polymorphism analysis of hsp65 has 
been reported to be useful in identifying all clinically 
crucial species of aerobic actinomycetes (Steingrube 
et  al. 1997). To identify atypical pathogens, 16S rRNA 
sequencing is a relatively rapid and reliable new molecu-
lar technique (Sheridan et al. 2005).
Optimal treatment of infections caused by Tsuka-
murella spp. is undetermined, mainly due to the rarity of 
infections caused by these pathogens and lack of standard 
susceptibility methods for Tsukamurella spp. The previ-
ous susceptibility reports have shown that Tsukamurella 
isolates were susceptible to aminoglycosides, macrolides, 
fusidic acid, imipenem, ciprofloxacin, trimethoprim and 
sulfamethoxazole, vancomycin, and teicoplanin, but 
resistant to penicillin, oxacillin, tetracycline, chloram-
phenicol, and expanded-spectrum cephalosporin (Liu 
et al. 2011).
To treat our patient with T. tyrosinosolvens sepsis, we 
used imipenem combined with trimethoprim and sul-
famethoxazole. The optimal length of treatment for 
infections caused by Tsukamurella spp. bacteria has not 
been determined and should be individualized according 
to clinical response. We maintained the treatment of our 
patient with T. tyrosinosolvens sepsis until the patient’s 
clinical symptoms markedly improved.
Human tuberculosis is caused principally by Mycobac-
terium tuberculosis. The main causative agents of bovine 
tuberculosis is Mycobacterium bovis and cattle are the 
major reservoir. The zoonotic transmission of this patho-
gens occurs primarily through close contact with infected 
cattle or consumption of contaminated animal products 
such as unpasteurized milk. Tuberculosis cases caused 
by transmission of mycobacteria from animal reservoirs 
(e.g., wildlife) have been anecdotally reported. Globally, 
most cases of zoonotic tuberculosis are caused by M. 
bovis (Müller et al. 2013).
Mycobacterium bovis is intrinsically resistant to 
pyrazinamide (PZA). The appropriate treatment for 
M. bovis is extrapolated from experience in treating 
PZA-resistant M. tuberculosis. For otherwise sensitive 
pulmonary and extrapulmonary M. bovis, treatment 
consists of 2  months of isoniazid, rifampin, and eth-
ambutol (administered daily), followed by 7  months of 
isoniazid and rifampin (LoBue and Moser 2005). The 
duration of therapy for pulmonary and most extrapul-
monary disease should be as least 9  months. For our 
patient, considering his immunocompromised state 
(diabetes HbA1C 9.2 and combined T. tyrosinosolvens 
bacteremia), we opted to maintain medical treatment 
for 12 months.
At the beginning of hospitalization, the initial acid-
fast-stain-positive bacteria result prompted us to con-
clude that the pathogens in pneumonia and blood were 
the same. Two sets of blood culture revealed T. tyrosi-
nosolvens made us to believe the result was not related 
to contamination of the culture process. And the trans-
bronchoscopy washing specimen culture did not reveal T. 
tyrosinosolvens after careful examination and incubation. 
After examining our patient’s medical history, we found 
that his son was a beef merchant, and our patient worked 
in the traditional Taiwanese market. Our patient did not 
have well diabetes control so the possible route of infec-
tion in our patient was environmental exposure through 
food consumption in an immunocompromised status. 
After discussing with our patient, he agreed and gave 
his consent to us for the use of his personal and medi-
cal information for the publication of this case report and 
any accompanying images.
Conclusion
According to our literature review, our patient’s case was 
the first of a coinfection with T. tyrosinosolvens and M. 
bovis. The similarity of these 2 types of organisms on the 
basis of conventional identification methods lead doctors 
to treat infections with these organisms incorrectly. Care-
ful and accurate identification of the bacteria causing an 
infection is necessary for patients with infections similar 
to that of our patient. Prolonged antibiotic treatment and 
underlying disease control are also necessary for this type 
of patient.
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